NICE recommends MSD’s pembrolizumab to treat melanoma

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Credit: Julio C. Valencia / commons.wikimedia.org.